Safety Study of Human IgM (MORAb-028) to Treat Metastatic Melanoma
Clinical trial NCT01123304 · TERMINATED
Trial details
- NCT number
- NCT01123304
- Sponsor
- Morphotek
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2012-03-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.